about
Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosisInterferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosisThe biology of mycobacterium tuberculosis infection.Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection.Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian center.Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy.Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in miceThe PPE domain of PPE17 is responsible for its surface localization and can be used to express heterologous proteins on the mycobacterial surfaceEvaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratoryPertussis in infants less than 6 months of age and household contacts, Italy, April 2014HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapyVaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy.Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector.Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells.HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study.Immune response to influenza A(H1N1)v in HIV-infected patients.HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects.PE is a functional domain responsible for protein translocation and localization on mycobacterial cell wall.Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection.Epidemic of tuberculosis in a high school in Northern Sardinia.In vitro effect of unacylated ghrelin and obestatin on human luteal cell function.Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome.Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli.PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo.Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli.Genetic diversity of bacterial strains isolated from soils, contaminated with polycyclic aromatic hydrocarbons, by 16S rRNA gene sequencing and amplified fragment length polymorphism fingerprinting.Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry.PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosisImproved protection in guinea pigs after vaccination with a recombinant BCG expressing MPT64 on its surfaceHomologous prime boosting based on intranasal delivery of non-pathogenic invasive Escherichia coli expressing MPT64, decreases Mycobacterium tuberculosis disseminationFunctional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 ofMycobacterium tuberculosisImmune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patientsFirst case of Tsukamurella pulmonis infection in an immunocompetent patientMycobacterium smegmatis Expressing a Chimeric Protein MPT64-Proteolipid Protein (PLP) 139–151 Reorganizes the PLP-Specific T Cell Repertoire Favoring a CD8-Mediated Response and Induces a Relapsing Experimental Autoimmune EncephalomyelitisEvaluation of the anti-tuberculosis activity generated by different multigene DNA vaccine constructs
P50
Q26852508-1C128090-CA75-48AE-9BB6-5EAF0248ABC2Q27321749-410E20E6-A968-4CB3-9408-D38F8F286370Q30357155-D0534BA9-0B9D-47E9-9ACB-64E1E951ED97Q30396646-607FA4CD-C7A7-42CE-8D98-FEA031FE0262Q30400820-482DF049-F8F0-48CA-A4BF-56AD73981B5FQ30408415-8EE91F0F-4A11-42FA-A838-10D2436818D1Q34309667-DFB2EDD8-9EE1-47CB-BEF3-787DA72FDB68Q34613099-5BED96F1-2099-41DB-9A4A-C6479BB18C3BQ35784345-90BBBD1C-5602-4B70-8942-C098409B6510Q35887218-92B82B0F-6305-464A-AB21-7DA09E764012Q36746765-C5263098-7DCF-4333-82E9-7778C15D0E63Q36870786-AD2D86BD-3032-49AC-9E06-7B6D37D3F22CQ39170352-718F388C-BEF4-4972-923C-58B8CF8337B9Q39654309-24E6528B-EA82-404B-8614-AAC9EF587203Q39781411-C3D80F62-561E-4989-B846-1078EF96E0EBQ41045517-94D5D749-FDC5-4659-BC34-4908547F93A5Q42205595-7309F9EF-EDEF-4861-BFC9-36244B25A0EFQ42243384-E76E86A8-A887-4B89-801C-2ABB4E641501Q42265061-74C00B03-EC42-48CD-B8D7-B81E7A8D6C65Q42637560-2B6C0196-43E4-4B3E-BB96-2C4315AF6FF9Q43707862-795A18B1-95F3-4B7B-BD7D-2073C9C5C273Q44614121-53BB7BDC-FD68-45F3-B858-5BE5A04504DFQ50971461-C346A7AD-67C1-4DCF-8B43-A2025EFB51D5Q51886595-4EF12120-221D-4203-8384-2D3C3777964AQ53266572-D51D00E2-9F19-41EB-8BCB-3F22BC3DD5CBQ54350735-F082E1D1-DCEB-4D90-B3B9-FB2ED979B4D7Q54425194-D72A5D53-DBA6-4CFA-BD4B-3540BE6BEF3BQ54621450-006CE357-B60F-41CC-B1EF-9FEB0F973412Q55340133-F0CC9CBB-B910-45EF-80E0-EA6F344E7B8BQ58453157-BE5475D7-0989-458F-8FE8-EB84F18C8430Q60920160-260B8F7B-25A0-46B5-8577-F6E97E7237BFQ60920166-64D0D55E-9D2B-48EF-B764-1270294F7D84Q60920169-84C03881-CD84-42C5-B276-894555A4E275Q61399372-65A7B7E6-E6AC-4460-847D-AFE81F28B215Q64133885-685EF08E-B99C-45E3-A809-8E12A529FC71Q64133889-829B040A-2F07-45B1-BEC9-00F0E03F359BQ64133897-B0B10970-7D4F-4D17-BB2C-54C997D69328
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michela Sali
@ast
Michela Sali
@en
Michela Sali
@es
Michela Sali
@nl
type
label
Michela Sali
@ast
Michela Sali
@en
Michela Sali
@es
Michela Sali
@nl
prefLabel
Michela Sali
@ast
Michela Sali
@en
Michela Sali
@es
Michela Sali
@nl
P106
P1153
23019660200
P31
P496
0000-0003-3609-2990